Skip to main content
. 2022 Sep 14;22:228. doi: 10.1186/s12902-022-01138-9

Table 1.

Baseline characteristics by metabolic syndrome status

Metabolic Syndrome a
Yes No p-value
n, % 1,656 (30.79) 3,497 (69.21)
Age, years 63 (11) 62 (12) 0.006
Sleep duration (hours), n (%)  < 6 202 (12.20) 417 (11.92)
 6- < 7 501 (30.25) 1,040 (29.74)
 7- < 8 543 (32.79) 1,236 (35.24)
 8- < 9 323 (19.50) 679 (19.42)
 ≥ 9 87 (5.25) 125 (3.57) 0.040
Insomnia (IRS ≥ 9), n (%) b 517 (31.78) 995 (29.01) 0.045
Waist circumference > 88 cm 1,329 (80.40) 898 (25.79) < 0.001
Hypertension, n (%) 1,358 (82.00) 1,482 (42.38) < 0.001
Fast glucose ≥ 100 mg/dL 984 (59.82) 402 (11.88) < 0.001
HDL < 50 mg/dL 1,053 (63.86) 396 (11.73) < 0.001
Triglycerides ≥ 150 mg/dL 1,181 (71.40) 697 (20.60) < 0.001
Observational Study, n (%) 227 (13.71) 756 (21.62) < 0.001
Dietary modification trial, n (%) 888 (53.62) 1,706 (48.78) 0.001
Calcium and Vitamin D suppl. trial, n (%) 728 (43.96) 1,474 (42.15) 0.220
HRT study arm, n (%) 910 (54.95) 1,546 (44.21) < 0.001
Use of sleep aids no 1,274 (76.93) 2,778(79.44)
 < 1t/wk 127 (7.67) 312 (8.92)
 1-2t/wk 84 (5.07) 161 (4.60)
 3-4t/wk 46 (2.78) 84 (2.40)
 ≥ 5t/wk 120 (7.25) 157 (4.49) 0.001
Body mass index, kg/m2 31.59 (7.27) 26.20 (6.27) < 0.001
Education< college 168 (10.24) 252 (7.25)
 some college 1,033 (62.99) 1,891 (54.39)
 college graduate 133 (8.11) 372 (10.70)
 post-college 306 (18.66) 962 (27.67) < 0.001
Ethnicity, n (%) White 851 (51.39) 1,918 (54.85)
Black 392 (23.67) 752 (21.50)
American Indian/Alaskan Native 52 (3.1) 66 (1.9)
Asian or Pacific Islander 99 (6.0) 289 (8.3)
Hispanic/Latino 237 (14.3) 409 (11.7)
Others 25 (1.5) 63 (1.8) < 0.001
Marital status, n (%)
 Never married 63 (3.8) 146 (4.2)
 Divorced/ Separated 300 (18.1) 610 (17.4)
 Widowed 313 (18.9) 592 (16.9)
 Married/ Marriage-like 969 (58.5) 2,130 (60.9)
 missed 11 (0.7) 19 (0.5) 0.341
Family income ($), n (%)
 < $35,000 831 (50.2) 1,402 (40.1)
 ≥ $35,000-< $50,000 318 (19.2) 687 (19.7)
 ≥ $50,000-< $75,000 261 (15.8) 634 (18.1)
 ≥ 75,000 194 (11.7) 658 (18.8)
 missed 52 (3.1) 115 (3.3) < 0.001
Cancer before enrollment, n (%) 70 (4.3) 153 (4.4) 0.791
Cardiovascular disease before enrollment. n (%) 242 (16.0) 469 (14.7) 0.240
Smoking, n(%) never 845 (51.03) 1,856 (53.07)
 former 645 (38.95) 1,322 (37.80)
 current 144 (8.70) 278 (7.95) 0.468
Pack-years of cigarette consumption 11.64 (20.96) 11.64 (25.58) 0.259
Hormone therapy use ever, n (%) 667 (40.28) 1,794 (51.30) < 0.001
Age at menopause, n (%) < 45 396 (32.49) 864 (31.10)
 45–49 441 (36.18) 985 (35.46)
 ≥ 50 382 (31.34) 929 (33.44) 0.410
Alcohol intake, serves /wk 3 (2) 4 (3) < 0.001
Coffee/tea intake cups/day 1.17 (1.59) 2.34 (1.59) 0.003
Physical activity, MET-hrs/wk 3.75 (10.50) 6.75 (15.75) < 0.001
Depression (≥ 5 short CES-D), n (%) 289 (17.50) 535 (15.39) 0.054

Data are medians and interquartile ranges, unless otherwise specified. P values from Wilcoxon rank test for continuous variables, and Chi-square test and t-test for categorical ones

Abbreviations: HDL High density lipoprotein, HRT Hormone replacement therapy, MET Metabolic equivalent, CES-D Center for epidemiological studies of depression

a Six women had missing information on MS at baseline

b Ninety six women had missing information on insomnia at baseline